Prevalence of readily detected amyloid blood clots in ‘unclotted’ Type 2 Diabetes Mellitus and COVID-19 plasma: a preliminary report

BACKGROUND: Type 2 Diabetes Mellitus (T2DM) is a well-known comorbidity to COVID-19 and coagulopathies are a common accompaniment to both T2DM and COVID-19. In addition, patients with COVID-19 are known to develop micro-clots within the lungs. The rapid detection of COVID-19 uses genotypic testing f...

Descripción completa

Detalles Bibliográficos
Autores principales: Pretorius, Etheresia, Venter, Chantelle, Laubscher, Gert Jacobus, Lourens, Petrus Johannes, Steenkamp, Janami, Kell, Douglas B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670290/
https://www.ncbi.nlm.nih.gov/pubmed/33203441
http://dx.doi.org/10.1186/s12933-020-01165-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670290/
https://www.ncbi.nlm.nih.gov/pubmed/33203441
http://dx.doi.org/10.1186/s12933-020-01165-7

Ejemplares similares